Beta Bionics Files Q1 2025 10-Q, Details Preferred Stock
Ticker: BBNX · Form: 10-Q · Filed: May 6, 2025 · CIK: 1674632
| Field | Detail |
|---|---|
| Company | Beta Bionics, Inc. (BBNX) |
| Form Type | 10-Q |
| Filed Date | May 6, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-Q, financials, preferred-stock
TL;DR
Beta Bionics Q1 10-Q out: Preferred stock, cash, and capital gains detailed. Looks solid.
AI Summary
Beta Bionics, Inc. filed its 10-Q for the period ending March 31, 2025. The company, focused on surgical and medical instruments, reported financial data for the first quarter of 2025. Key financial elements include Series C Preferred Stock, Series B Preferred Stock, and common stock, with significant activity in Additional Paid-In Capital and Accumulated Other Comprehensive Income.
Why It Matters
This filing provides insight into Beta Bionics' financial health and capital structure as of Q1 2025, which is crucial for investors assessing the company's stability and growth potential.
Risk Assessment
Risk Level: medium — The filing details preferred stock and other financial instruments, indicating potential complexity and risk associated with the company's capital structure.
Key Numbers
- 2025-03-31 — Reporting Period End Date (The 10-Q covers financial data up to this date.)
- 2025-01-01 — Start of Reporting Period (The Q1 2025 reporting period began on this date.)
- 2024-12-31 — Previous Year End Date (Financial data from the end of the previous fiscal year is referenced.)
- 2024-03-31 — Previous Year Q1 End Date (Comparative financial data from Q1 2024 is referenced.)
Key Players & Entities
- Beta Bionics, Inc. (company) — Filer of the 10-Q
- 20250331 (date) — End of reporting period
- 3841 (number) — Standard Industrial Classification for Surgical & Medical Instruments & Apparatus
- 475386878 (number) — Employer Identification Number (EIN)
- DE (state) — State of Incorporation
- 1231 (date) — Fiscal Year End
- 001-42491 (number) — SEC File Number
- 949-427-7785 (phone) — Business Phone Number
- us-gaap:SeriesCPreferredStockMember (financial_instrument) — Mentioned in filing
- us-gaap:SeriesBPreferredStockMember (financial_instrument) — Mentioned in filing
FAQ
What is Beta Bionics, Inc.'s primary business activity?
Beta Bionics, Inc. is classified under Standard Industrial Classification 3841, which pertains to Surgical & Medical Instruments & Apparatus.
What is the fiscal year end for Beta Bionics, Inc.?
The fiscal year end for Beta Bionics, Inc. is December 31 (1231).
What is the SEC file number for Beta Bionics, Inc.?
The SEC file number for Beta Bionics, Inc. is 001-42491.
Which preferred stock series are mentioned in the filing?
The filing mentions us-gaap:SeriesCPreferredStockMember and us-gaap:SeriesBPreferredStockMember.
What is the business address of Beta Bionics, Inc.?
The business address is 11 HUGHES, IRVINE, CA 92618.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 6, 2025 regarding Beta Bionics, Inc. (BBNX).